Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced today the successful closing of an oversubscribed $110 million Series C to ...
Capstan Medical, headquartered in the Wrigley Building on Santa Cruz's Westside, is heading to its first human trials with its minimally invasive treatment for heart valve disease.
Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...